Cohen Neil Harris — SEC insider filings

SEC reporting owner CIK 1840006. 10 insider filings on record with FilingPulse; latest filed 2026-09-01.

Transaction summary — filings shown

Covers all 10 filings on record, filed 2021-03-11 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Chemomab Therapeutics Ltd. (CMMB)Director106 legs · 12,409 sh · $147,3583 legs · 4,713 sh · $11,33424

Insider filings — Cohen Neil Harris

FiledFormIssuerReported transactionsSource
2026-09-014Chemomab Therapeutics Ltd. (CMMB)Sale (S): 1,304 @ $2.85 · Sale (S): 1,000 @ $2.80 · Grant/award (A): 172 (derivative) @ $0 · Grant/award (A): 2,971 (derivative) @ $0 · Grant/award (A): 1,705 (derivative) @ $0 · Grant/award (A): 1,714 (derivative) @ $0 · +3 moreEDGAR
2023-03-234Chemomab Therapeutics Ltd. (CMMB)Grant/award (A): 6,875 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0EDGAR
2022-11-184Chemomab Therapeutics Ltd. (CMMB)Sale (S): 2,409 @ $2 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0EDGAR
2022-05-194Chemomab Therapeutics Ltd. (CMMB)Purchase (P): 2,000 @ $3.19 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0EDGAR
2022-03-154Chemomab Therapeutics Ltd. (CMMB)Purchase (P): 2,000 @ $4.20 · Purchase (P): 2,000 @ $4.30 · Purchase (P): 2,000 @ $4.56 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0EDGAR
2022-03-094Chemomab Therapeutics Ltd. (CMMB)Grant/award (A): 6,820 (derivative) @ $0EDGAR
2021-12-084Chemomab Therapeutics Ltd. (CMMB)Purchase (P): 2,000 @ $7.43EDGAR
2021-04-214Chemomab Therapeutics Ltd. (CMMB)Grant/award (A): 11,884 (derivative) @ $0EDGAR
2021-03-264Chemomab Therapeutics Ltd. (CMMB)Purchase (P): 2,409 @ $41.51 · Purchase (P): 688 (derivative) @ $0EDGAR
2021-03-114Anchiano Therapeutics Ltd. (ANCN)Grant/award (A): 55,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1840006 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs